Patents by Inventor Protaffin Biotechnologie AG

Protaffin Biotechnologie AG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLYCOSAMINOGLYCAN-ANTAGONISING MCP-1 MUTANTS AND METHODS OF USING SAME
    Publication number: 20130150303
    Abstract: Novel mutants of human monocyte chemoattractant protein 1 (MCP-1) with increased glycosaminoglycan (GAG) binding affinity and knocked-out or reduced GPCR activity compared to wild type MCP-1, and their use for therapeutic treatment of inflammatory diseases.
    Type: Application
    Filed: December 17, 2012
    Publication date: June 13, 2013
    Applicant: PROTAFFIN BIOTECHNOLOGIE AG
    Inventor: Protaffin Biotechnologie AG